Difference between revisions of "Part:BBa K5082012"
Line 1: | Line 1: | ||
− | + | ===Usage and Biology=== | |
− | + | ||
− | 1 | + | Previously, it has been reported that gastric cancer (GC) tissue cells overexpress the oncogene G3BP1 [1]. Meanwhile, G3BP1 proteins have been proved to have HSU mRNA degrading activity[2]. Based on these findings, we designed and constructed the pCMV-EGFP-EI3B-HSU plasmid to utilize G3BP1’s HSU mRNA-degrading activity to detect G3BP1 concentration and thereby diagnose GC. To validate our theory, we deleted and altered a few nucleotides in the EIF3B-HSU sequence (BBa_K5082005) to form the EIF3B-MUT sequence (BBa_K5082006). Afterward, we constructed the pCMV-EGFP-EIF3B-MUT plasmid. |
+ | |||
+ | ===Design=== | ||
+ | The pCMV-EGFP-EIF3B-MUT plasmid is constructed by fusing the EIF3B-MUT sequence into the pCMV-EGFP vector backbone (BBa_K5082008). The EIF3B-MUT sequence is inserted downstream the GFP reporter gene contained in the plasmid backbone. Upon transcription, the EIF3B-MUT sequence will not form a highly structured 3’UTR (HSU) structure downstream the GFP gene due to the deletion and alteration of specific nucleotides. Therefore, G3BP1 proteins will not affect mRNA degradation and translation. The plasmid map for pCMV-EGFP-EIF3B-MUT is shown in Figure 1. | ||
+ | https://static.igem.wiki/teams/5407/cmvmut-1.png | ||
+ | Figure 1. pCMV-EGFP-EIF3B-MUT plasmid map. | ||
+ | ===Results=== | ||
+ | In our experiments, we used three cell lines. We used the GES-1 cell line to simulate healthy stomach cells and used the MGC-803 and AGS cell lines to simulate GC tissue cells. After transfecting the pCMV-EGFP-EIF3B-MUT plasmid into the three cell lines, we cultured the cells under identical conditions for 48 hours. Afterward, we qualitatively observed their fluorescence under fluorescence microscopes and quantitatively measured their fluorescence values using SpectraMax i3. The quantitative observation results are shown in Figure 1. The qualitative measurement results are shown in Figure 2 and Table 1. | ||
+ | https://static.igem.wiki/teams/5407/cmvmut-2.png | ||
+ | Figure 2. Fluorescence of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid observed under fluorescence microscopes. (A) GES-1 cell | ||
+ | line. (B) MGC-803 cell line. (C) AGS cell line. | ||
+ | |||
+ | https://static.igem.wiki/teams/5407/cmvmut-3.png | ||
+ | Figure 3. Fluorescence values of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid measured using SpectraMax i3. | ||
+ | |||
+ | Table 1. Fluorescence values of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid measured using SpectraMax i3. | ||
+ | https://static.igem.wiki/teams/5407/cmvmut-4.png | ||
+ | As shown in Figure 2, Figure 3 and Table 1, there is no significant difference in fluorescence between all three cell lines. This suggests that the different G3BP1 concentrations among the cell lines do not have an effect on mRNA without HSU regions, proving that our theory was correct. | ||
+ | |||
+ | ===Reference === | ||
+ | References | ||
+ | |||
+ | [1] Ge, Yidong et al. “The roles of G3BP1 in human diseases (review).” Gene vol. 821 (2022): 146294. doi:10.1016/j.gene.2022.146294 | ||
+ | |||
+ | [2] Xiong, Rui et al. “G3BP1 activates the TGF-β/Smad signaling pathway to promote gastric cancer.” OncoTargets and therapy vol. 12 7149-7156. 2 Sep. 2019, doi:10.2147/OTT.S213728 | ||
− | |||
− | |||
<!-- --> | <!-- --> |
Revision as of 12:12, 7 September 2024
Contents
Usage and Biology
Previously, it has been reported that gastric cancer (GC) tissue cells overexpress the oncogene G3BP1 [1]. Meanwhile, G3BP1 proteins have been proved to have HSU mRNA degrading activity[2]. Based on these findings, we designed and constructed the pCMV-EGFP-EI3B-HSU plasmid to utilize G3BP1’s HSU mRNA-degrading activity to detect G3BP1 concentration and thereby diagnose GC. To validate our theory, we deleted and altered a few nucleotides in the EIF3B-HSU sequence (BBa_K5082005) to form the EIF3B-MUT sequence (BBa_K5082006). Afterward, we constructed the pCMV-EGFP-EIF3B-MUT plasmid.
Design
The pCMV-EGFP-EIF3B-MUT plasmid is constructed by fusing the EIF3B-MUT sequence into the pCMV-EGFP vector backbone (BBa_K5082008). The EIF3B-MUT sequence is inserted downstream the GFP reporter gene contained in the plasmid backbone. Upon transcription, the EIF3B-MUT sequence will not form a highly structured 3’UTR (HSU) structure downstream the GFP gene due to the deletion and alteration of specific nucleotides. Therefore, G3BP1 proteins will not affect mRNA degradation and translation. The plasmid map for pCMV-EGFP-EIF3B-MUT is shown in Figure 1.
Figure 1. pCMV-EGFP-EIF3B-MUT plasmid map.
Results
In our experiments, we used three cell lines. We used the GES-1 cell line to simulate healthy stomach cells and used the MGC-803 and AGS cell lines to simulate GC tissue cells. After transfecting the pCMV-EGFP-EIF3B-MUT plasmid into the three cell lines, we cultured the cells under identical conditions for 48 hours. Afterward, we qualitatively observed their fluorescence under fluorescence microscopes and quantitatively measured their fluorescence values using SpectraMax i3. The quantitative observation results are shown in Figure 1. The qualitative measurement results are shown in Figure 2 and Table 1.
Figure 2. Fluorescence of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid observed under fluorescence microscopes. (A) GES-1 cell line. (B) MGC-803 cell line. (C) AGS cell line.
Figure 3. Fluorescence values of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid measured using SpectraMax i3.
Table 1. Fluorescence values of cell lines transfected with pCMV-EGFP-EIF3B-MUT plasmid measured using SpectraMax i3.
As shown in Figure 2, Figure 3 and Table 1, there is no significant difference in fluorescence between all three cell lines. This suggests that the different G3BP1 concentrations among the cell lines do not have an effect on mRNA without HSU regions, proving that our theory was correct.
Reference
References
[1] Ge, Yidong et al. “The roles of G3BP1 in human diseases (review).” Gene vol. 821 (2022): 146294. doi:10.1016/j.gene.2022.146294
[2] Xiong, Rui et al. “G3BP1 activates the TGF-β/Smad signaling pathway to promote gastric cancer.” OncoTargets and therapy vol. 12 7149-7156. 2 Sep. 2019, doi:10.2147/OTT.S213728
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal EcoRI site found at 1684
Illegal XbaI site found at 1721
Illegal SpeI site found at 270
Illegal PstI site found at 1689
Illegal PstI site found at 3043 - 12INCOMPATIBLE WITH RFC[12]Illegal EcoRI site found at 1684
Illegal NheI site found at 916
Illegal SpeI site found at 270
Illegal PstI site found at 1689
Illegal PstI site found at 3043 - 21INCOMPATIBLE WITH RFC[21]Illegal EcoRI site found at 1684
Illegal BglII site found at 1664
Illegal BglII site found at 6170
Illegal BamHI site found at 1715
Illegal XhoI site found at 1668 - 23INCOMPATIBLE WITH RFC[23]Illegal EcoRI site found at 1684
Illegal XbaI site found at 1721
Illegal SpeI site found at 270
Illegal PstI site found at 1689
Illegal PstI site found at 3043 - 25INCOMPATIBLE WITH RFC[25]Illegal EcoRI site found at 1684
Illegal XbaI site found at 1721
Illegal SpeI site found at 270
Illegal PstI site found at 1689
Illegal PstI site found at 3043
Illegal NgoMIV site found at 2153
Illegal NgoMIV site found at 3494
Illegal NgoMIV site found at 3777
Illegal AgeI site found at 925 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 903
Illegal BsaI.rc site found at 5302
Illegal SapI site found at 4222
Illegal SapI.rc site found at 3343
Illegal SapI.rc site found at 3553